{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:32:48Z","timestamp":1772148768624,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["108-2314-B-002-191-MY3"],"award-info":[{"award-number":["108-2314-B-002-191-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-0210-01-18-02"],"award-info":[{"award-number":["109-0210-01-18-02"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-2811-B-002-627"],"award-info":[{"award-number":["109-2811-B-002-627"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2113-M-002-007"],"award-info":[{"award-number":["110-2113-M-002-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-002-271-MY3"],"award-info":[{"award-number":["111-2314-B-002-271-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-SUMMIT-109"],"award-info":[{"award-number":["AS-SUMMIT-109"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2023.116042","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:05:56Z","timestamp":1702605956000},"page":"116042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition"],"prefix":"10.1016","volume":"265","author":[{"given":"Yu-Wei","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Ling","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyung-Hurng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Chen","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tse-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-0434","authenticated-orcid":false,"given":"Szu-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Jen Rachel","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim-Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116042_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.116042_bib2","article-title":"Physical and functional HAT\/HDAC interplay regulates protein acetylation balance","volume":"2011","author":"Peserico","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.116042_bib3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylases inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.116042_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.116042_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2023.116042_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.116042_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.116042_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.116042_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12282-010-0224-7","article-title":"The microtubule as a breast cancer target","volume":"18","author":"Higa","year":"2011","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejmech.2023.116042_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/med.20242","article-title":"Drugs that target dynamic microtubules: a new molecular perspective","volume":"31","author":"Stanton","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.116042_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/CAD.0000000000000080","article-title":"Taxanes, past, present, and future impact on non-small cell lung cancer","volume":"25","author":"Joshi","year":"2014","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejmech.2023.116042_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceb.2009.11.008","article-title":"From signaling pathways to microtubule dynamics: the key players","volume":"22","author":"Etienne-Manneville","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116042_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1042\/BST0371007","article-title":"Regulation of microtubule dynamic instability","volume":"37","author":"van der Vaart","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2023.116042_bib14","first-page":"2561","article-title":"Microtubule-severing enzymes at the cutting edge","volume":"125","author":"Sharp","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2023.116042_bib15","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1021\/acs.jmedchem.6b00797","article-title":"Purine-type compounds induce microtubule fragmentation and lung cancer cell death through interaction with katanin","volume":"59","author":"Kuo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.07.054","article-title":"Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer","volume":"181","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib17","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1158\/1078-0432.CCR-07-1385","article-title":"Targeted agents: the rules of combination","volume":"13","author":"Kwak","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.116042_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/449993a","article-title":"Cancer: mixing cocktails","volume":"449","author":"Sawyers","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116042_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.116042_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.116042_bib21","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.2174\/138161212800626193","article-title":"Tubulins as therapeutic targets in cancer: from bench to bedside","volume":"18","author":"Katsetos","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2023.116042_bib22","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2023.116042_bib23","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1021\/acs.jmedchem.1c00100","article-title":"Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy","volume":"64","author":"Shuai","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib24","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-06-0209","article-title":"Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells","volume":"5","author":"Dowdy","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2023.116042_bib25","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2188","article-title":"The trouble with making combination drugs","volume":"5","author":"Frantz","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.116042_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.116042_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116042_bib29","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1021\/jm400179b","article-title":"Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase for cancer treatment","volume":"55","author":"Chen","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112904","article-title":"Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors","volume":"209","author":"Bass","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15252\/emmm.201404580","article-title":"A DNA\/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency","volume":"7","author":"Liu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2023.116042_bib32","doi-asserted-by":"crossref","first-page":"8436","DOI":"10.1021\/jo010595w","article-title":"The reactions of diaminomaleonitrile with isocyanates and either aldehydes or ketones revisited","volume":"66","author":"Booth","year":"2001","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/00397910903026723","article-title":"Synthesis of hydroxamic acid by activation of carboxylic acids with N, N\u2032- carbonyldiimidazole: exploring the efficiency of the method","volume":"40","author":"Usachova","year":"2010","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2023.116042_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bioorg.2016.05.005","article-title":"Inhibitors of histone deacetylase as antitumor agents: a critical review","volume":"67","author":"Manal","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib35","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1158\/1078-0432.CCR-06-1802","article-title":"A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer","volume":"12","author":"Rubin","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.116042_bib36","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2174\/092986705774454706","article-title":"Non-hydroxamate histone deacetylase inhibitors","volume":"12","author":"Suzuki","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib37","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/jo400406g","article-title":"Computational exploration of zinc binding groups for HDAC inhibition","volume":"78","author":"Chen","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib38","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1016\/j.bmcl.2016.08.073","article-title":"Design, synthesis and in vitro evaluation of amidoximes as histone deacetylase inhibitors for cancer therapy","volume":"26","author":"Jiao","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.116042_bib39","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1055\/s-0033-1341124","article-title":"One-pot oxidative conversion of alcohols into nitriles by using a TEMPO\/PhI(OAc)2\/NH4OAc system","volume":"25","author":"Vatele","year":"2014","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2023.116042_bib40","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/anie.201310164","article-title":"Total synthesis of the antimitotic marine macrolide (\u2013)-leiodermatolide","volume":"53","author":"Paterson","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2023.116042_bib41","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.bmc.2005.12.047","article-title":"Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: potent inhibition of histone deacetylases","volume":"14","author":"Gu","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib42","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/S0040-4039(00)00769-3","article-title":"A simple and efficient protocol for epoxidation of olefins using dimethyldioxirane","volume":"41","author":"Ferraz","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2023.116042_bib43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bmcl.2004.12.024","article-title":"The evolution of synthetic oral drug properties","volume":"15","author":"Proudfoot","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.116042_bib44","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1021\/jm900648x","article-title":"Hydroxamates: relationships between structure and plasma stability","volume":"52","author":"Flipo","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1358\/dof.2007.032.04.1094476","article-title":"Panobinostat","volume":"32","author":"Revill","year":"2007","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2023.116042_bib46","first-page":"721","article-title":"Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.)","volume":"2","author":"Plumb","year":"2003","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2023.116042_bib47","series-title":"Pyridine: A Useful Ligand in Transition Metal Complexes","author":"Pal","year":"2018"},{"key":"10.1016\/j.ejmech.2023.116042_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejmech.2016.05.047","article-title":"Inside HDACs with more selective HDAC inhibitors","volume":"121","author":"Roche","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"37","key":"10.1016\/j.ejmech.2023.116042_bib49","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116042_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cub.2011.03.051","article-title":"Cell migration: katanin gives microtubules a trim","volume":"21","author":"Baas","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2023.116042_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/596289","article-title":"Models, regulations, and functions of microtubule severing by katanin","volume":"2012","author":"Ghosh","year":"2012","journal-title":"ISRN Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116042_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pros.21431","article-title":"Aberrant expression of katanin p60 in prostate cancer bone metastasis","volume":"72","author":"Ye","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2023.116042_bib53","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1096\/fj.06-7254com","article-title":"LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin","volume":"21","author":"Sudo","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2023.116042_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4062\/biomolther.2019.074","article-title":"A new histone deacetylase inhibitor, MHY4381, induces apoptosis via generation of reactive oxygen species in human prostate cancer cells","volume":"28","author":"Richa","year":"2020","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"1","key":"10.1016\/j.ejmech.2023.116042_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2013.05.020","article-title":"Class I HDACs share a common mechanism of regulation by inositol phosphates","volume":"51","author":"Millard","year":"2013","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.ejmech.2023.116042_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2023.116042_bib57","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci500209e","article-title":"AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins","volume":"54","author":"Santos-Martins","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.116042_bib58","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2004"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:46:49Z","timestamp":1736866009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423010097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":58,"alternative-id":["S0223523423010097"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116042","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116042"}}